COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,722 Articles (22,913 medRxiv, 8,809 bioRxiv)

Most recent first Previous |  Page 493: Articles 4921-4930  | Next

Risk of Adverse Maternal and Fetal Outcomes Associated with COVID-19 Variants of Concern: A Sequential Prospective Meta-Analysis
Farooq, F., Oakley, E. M., Kerchner, D., Kim, J. Y. H., Akelo, V., Tippett Barr, B. A., Bevilacqua, E., Bracero, N., del Mar Gil, M., Delgado-Lopez, C., Favre, G., Fernandez Buhigas, I., Leung, H. Y. H., Laurita Longo, V., Panchaud, A., Poon, L. C., Martinez-Portilla, R. J., Valencia-Prado, M., Tielsch, J. M., Smith, E. R., The COVI-PREG International Registry, , The PMA collaborators
10.1101/2023.04.03.23287260 — Posted: 2023-04-04
Stratification of Pediatric COVID-19 cases by inflammatory biomarker profiling and machine learning
Subramanian, D., Vittala, A., Chen, X., Julien, C., Acosta, S., Rusin, C., Allen, C., Rider, N., Starosolski, Z., Annapragada, A. A., Devaraj, S.
10.1101/2023.04.04.23288117 — Posted: 2023-04-04
Long-term outcomes of COVID-19 infection in children and young people: a systematic review and meta-analysis
Twohig, H., Bajpai, R., Corp, N., Faux-Nightingale, A., Mallen, C., Robinson, T., Somayajula, G., van der Windt, D., Welsh, V., Burton, C.
10.1101/2023.04.04.23288110 — Posted: 2023-04-04
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
Michael, B. D., Dunai, C., Needham, E. J., Tharmaratnam, K., Williams, R., Huang, Y., Boardman, S. A., Clark, J., Sharma, P., Subramaniam, K., Wood, G. K., Collie, C., Digby, R., Ren, A., Norton, E., Leibowitz, M., Ebrahimi, S., Fower, A., Fox, H., Tato, E., Ellul, M., Sunderland, G., Held, M., Hetherington, C., Nkongho, F., Palmos, A., Grundmann, A., Stewart, J. P., Griffiths, M., Solomon, T., Breen, G., Coles, A., Cavanagh, J., Irani, S. R., Vincent, A., Taams, L., Menon, D. K.
10.1101/2023.04.03.23287902 — Posted: 2023-04-04
Early Treatment with Hydroxychloroquine and Azithromycin: A Real-Life Monocentric Retrospective Cohort Study of 30,423 COVID-19 Patients
Million, M., Cortaredona, S., Delorme, L., Colson, P., LEVASSEUR, A., Tissot-Dupont, H., bendamardji, K., Lahouel, S., LA SCOLA, B., Camoin, L., Fenollar, F., Gautret, P., Parola, P., Lagier, J.-C., Gentile, S., BROUQUI, P., Raoult, D.
10.1101/2023.04.03.23287649 — Posted: 2023-04-04
Longitudinal Analysis of Humoral and Cellular Immune Response Following SARS-CoV-2 Vaccination Supports Utilizing Point-Of-Care Tests to Enhance COVID-19 Booster Uptake.
Mallory, M., Munt, J. E., Narowski, T. M., Castillo, I., Cuadra, E., Pisanic, N., Fields, P., Powers, J. M., Dickson, A., Harris, R., Wargowsky, R., Moran, S., Allabban, A., Raphel, K., McCaffrey, T. A., Brien, J. D., Heaney, C. D., Lafleur, J. E., Baric, R. S., Premkumar, L.
10.1101/2023.04.03.23287498 — Posted: 2023-04-04
SARS-CoV-2 infection and post-acute risk of non-Covid-19 infectious disease hospitalizations: a nationwide cohort study of Danish adults aged >=50 years
Andersson, N. W., Thiesson, E. M., Lassauniere, R., Hansen, J. V., Hviid, A.
10.1101/2023.04.03.23288102 — Posted: 2023-04-04
The Functional RNA Identification (FRID) Pipeline: Identification of Potential Pseudoknot-Containing RNA Elements as Therapeutic Targets for SARS-CoV-2
Forstmeier, P. C., Meyer, M. O., Bevilacqua, P. C.
10.1101/2023.04.03.535424 — Posted: 2023-04-04
Chemical-guided SHAPE sequencing (cgSHAPE-seq) informs the binding site of RNA-degrading chimeras targeting SARS-CoV-2 5' untranslated region
Tang, Z., Hegde, S., Hao, S., Selvaraju, M., Qiu, J., Wang, J.
10.1101/2023.04.03.535453 — Posted: 2023-04-04
Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 Spike ferritin nanoparticle vaccine antigen produced from two different cell lines
Kumru, O., Sanyal, M., Friedland, N., Hickey, J., Joshi, R., Weidenbacher, P., Do, J., Cheng, Y.-C., Kim, P. S., Joshi, S. B., Volkin, D. B.
10.1101/2023.04.03.535447 — Posted: 2023-04-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).